GEODE CAPITAL MANAGEMENT, LLC

Position in DRMA — Dermata Therapeutics, Inc.

CIK 1214717 BOSTON, MA

Position in DRMA

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$26,061

-$32,422 QoQ

Shares Held

20,203

-58.2% QoQ

Ownership

0.502%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

of 13 holders

Holding Since

Sep 2021

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $21,877,764,044 across 520 Biotechnology names. DRMA ranks #501 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	6,017,848	$2,989,245,636
2	REGN	Regeneron Pharmaceuticals, Inc.	2,625,810	$1,637,297,566
3	ALNY	Alnylam Pharmaceuticals, Inc.	2,635,840	$793,466,914
4	RVMD	Revolution Medicines, Inc.	3,942,676	$738,384,360
5	MRNA	Moderna, Inc.	9,710,335	$680,014,759
6	INCY	Incyte Corp	4,750,735	$538,543,319
7	RPRX	Royalty Pharma plc	8,058,048	$451,814,751
8	INSM	INSMED Inc	4,220,155	$449,952,925

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$26,061	20,203	-58.2%	Shares	Defined	2026-08-12
2026-03-31	$58,483	48,334	+76.5%	Shares	Defined	2026-05-15
2025-06-30	$16,020	27,385	+34.2%	Shares	Defined	2025-08-08
2025-03-31	$22,038	20,406	+66.8%	Shares	Defined	2025-05-13
2024-03-31	$5,029	12,237	0.0%	Shares	Defined	2024-05-13
2023-12-31	$7,464	12,237	0.0%	Shares	Defined	2024-02-13
2023-09-30	$12,971	12,237	-54.1%	Shares	Defined	2023-11-13
2022-12-31	$10,906	26,666	0.0%	Shares	Defined	2023-02-13
2022-09-30	$13,866	26,666	0.0%	Shares	Defined	2022-11-14
2022-06-30	$17,332	26,666	0.0%	Shares	Defined	2022-08-12
2022-03-31	$33,332	26,666	0.0%	Shares	Defined	2022-05-13
2021-12-31	$46,398	26,666	+68.1%	Shares	Defined	2022-02-11
2021-09-30	$71,211	15,860	—	Shares	Defined	2021-11-12
No filing history on record for this holder in this stock.